HRES 489
113th Congress
House
International Affairs
Aging
Foreign aid and international relief
Health programs administration and funding
Health promotion and preventive care
Medical research
Neurological disorders
Public-private cooperation
World health
Expressing the sense of Congress regarding the need to facilitate and promote a robust response to the looming global crisis of Alzheimer's and other forms of dementia.
Introduced: February 25, 2014
Introduced by:
Smith, Christopher H.
Republican
· New Jersey
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 28, 2014
Referred to the Subcommittee on Health.
Feb 25, 2014
Referred to the Committee on Foreign Affairs, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 25, 2014
Introduced in House
Plain-English summary
States that it should be the policy of the U.S. government to encourage and facilitate the following efforts concerning Alzheimer's disease and other forms of dementia:
- entry by the Secretary of Health and Human Services (HHS) into negotiations with the World Health Organization to develop a Global Alzheimer's and Dementia Action Plan;
- involvement of all other nations that have adopted national Alzheimer's and/or dementia plans or strategies;
- development of the foundation for a Global Alzheimer's Fund that would provide resources to support implementation of specific strategies of the Global Plan and assignment of a high-level person to lead and coordinate initiatives;
- investigation by the G8 nations of systems to monitor and provide care to persons with Alzheimer's and other forms of dementia in developing countries to help build care delivery capacity;
- investigation by the U.S. Agency for International Development (USAID) of the foreign aid implications of Alzheimer's and other forms of dementia and inform Congress of the need for possible changes to health care-related foreign assistance; and
- encouragement and facilitation of partnerships with the private sector, such as the current partnership between the National Institutes of Health (NIH) and 10 pharmaceutical companies to identify new approaches to treat Alzheimer's and other medical conditions.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3